首页 | 本学科首页   官方微博 | 高级检索  
检索        

44例热化疗在卵巢癌中的临床观察分析
引用本文:丁娟,符慧群.44例热化疗在卵巢癌中的临床观察分析[J].实用预防医学,2006,13(3):725-726.
作者姓名:丁娟  符慧群
作者单位:中南大学湘雅三医院肿瘤科,湖南,长沙,410013
摘    要:目的探讨热化疗对于晚期卵巢癌的近期治疗效果,3年生存率和毒副反应的影响。方法44例晚期卵巢癌患者均经过手术病理分期,随机分成热化疗组和化疗组,比较两组的近期疗效,3年生存率和毒副反应的发生率。结果热疗组的近期疗效明显高于化疗组(P<0.05)。热疗组的3年生存率为65%高于化疗组(48%),但没有统计学上的差异。两组毒副反应的发生率相似,症状轻微,可以耐受。结论热化疗治疗卵巢癌患者有好的近期疗效,毒副反应小,有望提高晚期卵巢癌患者的5年生存率。

关 键 词:热疗  化疗  恶性卵巢肿瘤
文章编号:1006-3110(2006)03-0725-02
收稿时间:2006-02-23
修稿时间:2006年2月23日

Observation on Hyperthermia Combined Chemotherapy in Treatment of Ovarian Carcinoma
DING Juan,FU Hui-qun.Observation on Hyperthermia Combined Chemotherapy in Treatment of Ovarian Carcinoma[J].Practical Preventive Medicine,2006,13(3):725-726.
Authors:DING Juan  FU Hui-qun
Institution:Department of Oncology, the Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, China
Abstract:Objective To investigate the clinical effect of adjuvant treatment for ovarian carcinoma with hyperthermia combined chemotherapy. Methods Forty-four patients with late ovarian carcinoma received surgical resection and pathological staging were randomized 23 patients to receive adjuvant hyperthermia and chemotherapy, and 21 patients to receive conventional chemotherapy alone; and the short-term effect, 3-year survival rates and adverse side effects were compared. Results Patients received hyperthermia and chemotherapy resulted in better outcomes as compared with chemotherapy alone in the short-term effect and the 3-year survival rates, but only the short-term effect reached significant difference (P<0.05). The side effects between these two groups were similar. Conclusion Adjuvant hyperthermia combined with chemotherapy is effective in the treatment of ovarian carcinoma, and the side effects are tolerable.
Keywords:Hyperthermia  Chemotherapy  Ovarian Carcinoma
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号